STAT+: Most-favored nations policy makes drugmakers rethink launches abroad
Ex-employee says Lilly promoted GLP-1 drug off-label A former Eli Lilly sales rep filed a lawsuit alleging that she was fired after complaining that the company promoted its Mounjaro diabetes drug as a weight loss treatment before receiving regulatory approval to do so.
Key points
- Continue to STAT+ to read the full story….
- Sign up to get our biotech newsletter in your inbox.
Thanksgiving is approaching and I’ve yet to make an all-butter pie crust that doesn’t shrink.
Want to stay on top of the science and politics driving biotech today?
How this summary was made: extractive summary — built from the sources' own reporting. It is drawn only from the reporting of the sources listed below — read the originals for full detail. How we summarize →
Advertisement
Every article behind this summary — 1 article from 1 outlet
Get stories like this in your inbox.
Subscribe — it's freeOne free email at 6am — your topics, deduplicated, five minutes. No account, no paywall.